LLY

1,085.59

+1.84%↑

JNJ

231.35

+0.49%↑

ABBV

215.42

+1.31%↑

UNH

384.08

+1.74%↑

MRK

120.33

+0.58%↑

LLY

1,085.59

+1.84%↑

JNJ

231.35

+0.49%↑

ABBV

215.42

+1.31%↑

UNH

384.08

+1.74%↑

MRK

120.33

+0.58%↑

LLY

1,085.59

+1.84%↑

JNJ

231.35

+0.49%↑

ABBV

215.42

+1.31%↑

UNH

384.08

+1.74%↑

MRK

120.33

+0.58%↑

LLY

1,085.59

+1.84%↑

JNJ

231.35

+0.49%↑

ABBV

215.42

+1.31%↑

UNH

384.08

+1.74%↑

MRK

120.33

+0.58%↑

LLY

1,085.59

+1.84%↑

JNJ

231.35

+0.49%↑

ABBV

215.42

+1.31%↑

UNH

384.08

+1.74%↑

MRK

120.33

+0.58%↑

Home・Lista de Ações・ResMed Inc

ResMed Inc

Fechado

SetorSaúde

206.23 -0.76

Comprar Vender

Visão Geral

Variação de preço das ações

24h

Atual

Mín

205.59

Máximo

211.21

Indicadores-chave
By Trading Economics
Rendimento	6.1M 399M
Vendas	8.6M 1.4B
P/E Médio do Setor	20.082 50.102
EPS	2.86
Rendimento de Dividendos	1.11
Margem de lucro	27.856
Funcionários	10,600
EBITDA	-67M 500M

Recomendações
By TipRanks
Recomendações	Comprar
Previsão para 12 meses	+27.2% upside

Dividendos
By Dow Jones
Rendimento de Dividendos Médio do Setor	1.11% 2.33%
Próximos Ganhos	30 de jul. de 2026
Próxima data de dividendos	18 de jun. de 2026
Próxima data de ex-dividendo	13 de ago. de 2026

Estatísticas de Mercado
By TradingEconomics
Capitalização de Mercado	-2.2B 30B
Abertura anterior	206.99
Fecho anterior	206.23

Sentimento de Notícias

By Acuity

34%

66%

64 / 344 Ranking em Healthcare

ResMed Inc Gráfico

O desempenho passado não é um indicador confiável de resultados futuros.

Notícias Relacionadas

27 de mai. de 2026, 21:33 UTC

Ganhos

Correction to Salesforce 1Q Sales, Profit Rise Article

27 de mai. de 2026, 21:00 UTC

Aquisições, Fusões, Aquisições de Empresas

HCA Healthcare Agrees to Buy The College of Health Care Professions

27 de mai. de 2026, 20:18 UTC

Ganhos

Salesforce 1Q Sales, Profit Rise Amid Agentforce Efforts

27 de mai. de 2026, 23:49 UTC

Conversa de Mercado

Nikkei Might Decline Amid Uncertainty Over Potential U.S.-Iran Peace Deal -- Market Talk

27 de mai. de 2026, 23:39 UTC

Conversa de Mercado

Congo Copper, Cobalt Mining Not yet Seen Affected by Ebola Outbreak -- Market Talk

27 de mai. de 2026, 23:34 UTC

Conversa de Mercado

Infratil's Longroad Energy Considers Data-Center Strategy -- Market Talk

27 de mai. de 2026, 23:34 UTC

Conversa de Mercado

Global Equities Roundup: Market Talk

27 de mai. de 2026, 23:08 UTC

Conversa de Mercado

Chinese Coal-Mine Disruptions Could Be Major Supply Shock for Global Markets -- Market Talk

27 de mai. de 2026, 22:21 UTC

Conversa de Mercado

Salesforce Lays Out AI Monetization Strategy -- Market Talk

27 de mai. de 2026, 21:29 UTC

Ações em Alta

Stocks to Watch: Marvell Technology, PDD, Zscaler -- WSJ

27 de mai. de 2026, 21:08 UTC

Ganhos

Marvell's Data-Center Boom Powers Earnings Beat. Its Stock Surges. -- Barrons.com

27 de mai. de 2026, 21:02 UTC

Ganhos

Salesforce Stock Slides on Mixed Results. CFO Touts New Pricing Model. -- Barrons.com

27 de mai. de 2026, 20:59 UTC

Aquisições, Fusões, Aquisições de Empresas

What to Know About Pasqal, the Quantum Start-Up Going Public Soon -- Barrons.com

27 de mai. de 2026, 20:55 UTC

Ganhos

Snowflake Stock Jumps 34%. How Amazon and an Earnings Beat Are Fueling the Gains. -- Barrons.com

27 de mai. de 2026, 20:50 UTC

Conversa de Mercado

Financial Services Roundup: Market Talk

27 de mai. de 2026, 20:48 UTC

Ganhos

Marvell's Data-Center Boom Powers Earnings Beat -- and a Big Stock Surge -- Barrons.com

27 de mai. de 2026, 20:45 UTC

Ganhos

Marvell Stock Jumps on Earnings. Data-Center Revenue Is Still Booming. -- Barrons.com

27 de mai. de 2026, 20:34 UTC

Aquisições, Fusões, Aquisições de Empresas

Webster Financial Stockholders Approve Sale to Banco Santander

27 de mai. de 2026, 20:32 UTC

Ganhos

Aquisições, Fusões, Aquisições de Empresas

Synopsys Shares Fall Despite Earnings Beat With AI and Merger in Focus -- Barrons.com

27 de mai. de 2026, 20:32 UTC

Aquisições, Fusões, Aquisições de Empresas

HCA Healthcare to Acquire The College of Health Care Professions for Undisclosed Terms >HCA

27 de mai. de 2026, 20:32 UTC

Aquisições, Fusões, Aquisições de Empresas

HCA Healthcare: Eric Bing Will Continue to Lead CHCP as Chancellor and CEO >HCA

27 de mai. de 2026, 20:30 UTC

Ganhos

Snowflake Beats Expectations and Expands AWS Ties Amid Software Sector Turmoil -- Barrons.com

27 de mai. de 2026, 20:30 UTC

Aquisições, Fusões, Aquisições de Empresas

HCA Healthcare Announces Agreement To Acquire The College Of Health Care Professions >HCA

27 de mai. de 2026, 20:22 UTC

Ganhos

Salesforce Stock Slides on Mixed Results -- Barrons.com

27 de mai. de 2026, 20:16 UTC

Ganhos

Salesforce Stock Slides on Mixed Results -- Barrons.com

27 de mai. de 2026, 20:13 UTC

Ganhos

Synopsys Sees 3Q Adj EPS $3.63-Adj EPS $3.69 >SNPS

27 de mai. de 2026, 20:13 UTC

Ganhos

Marvell Revenue Beats Estimates. The Stock Rises. -- Barrons.com

27 de mai. de 2026, 20:13 UTC

Ganhos

Synopsys Sees FY Adj EPS $14.72-Adj EPS $14.80 >SNPS

27 de mai. de 2026, 20:12 UTC

Ganhos

Synopsys Sees FY EPS $2.49-EPS $2.91 >SNPS

27 de mai. de 2026, 20:12 UTC

Ganhos

Synopsys Sees 3Q EPS 84c-EPS 98c >SNPS

Comparação entre Pares

Variação de preço

ResMed Inc Previsão

Preço-alvo

By TipRanks

27.2% parte superior

Previsão para 12 meses

Média 264.56 USD 27.2%

Máximo 340 USD

Mínimo 225 USD

Com base em 13 analistas de Wall Street que oferecem metas de preço de 12 meses para ResMed Inc - Dist nos últimos 3 meses.

Consenso de Avaliação

By TipRanks

Comprar

13 ratings

Comprar

Manter

Vender

Com base em 13 analistas que deram avaliações de ações para ResMed Inc - Dist nos últimos 3 meses.

Sentimento

By Acuity

64 / 344 Ranking em Saúde

Informação Financeira

Custos administrativos e de venda

Custos Operacionais

Lucro antes de imposto

Vendas

Custo das vendas

Lucro bruto sobre vendas

Despesa com juros da dívida

EBITDA

Resultado Operacional

Sobre ResMed Inc

ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications for the healthcare markets. The company operates in two segments, Sleep and Respiratory Care, and Software as a Service. It offers various products and solutions for a range of respiratory disorders, including ApneaLink Air, a portable diagnostic device that measures oximetry, respiratory effort, pulse, nasal flow, and snoring; and NightOwl, a portable, cloud-connected, and disposable diagnostic device that measures AHI based on derived peripheral arterial tone, actigraphy, and oximetry over several nights. The company also provides AirView, a cloud-based system that enables remote monitoring and changing of patients' device settings; myAir, a personalized therapy management application for patients with sleep apnea that provides support, education, and troubleshooting tools for increased patient engagement and improved compliance; U-Sleep, a compliance monitoring solution that enables home medical equipment (HME) to streamline their sleep programs; connectivity module and propeller solutions; and Propeller portal. It offers out-of-hospital software solution, such as Brightree business management software and service solutions to providers of HME, pharmacy, home infusion, orthotics, and prosthetics services; MatrixCare care management and related ancillary solutions to senior living, skilled nursing, life plan communities, home health, home care, and hospice organizations, as well as related accountable care organizations; HEALTHCAREfirst that offers electronic health record, software, billing and coding services, and analytics for home health and hospice agencies; and MEDIFOX DAN's software solutions. The company markets its products to sleep clinics, home healthcare dealers, and hospitals through a network of distributors and direct sales force. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California.